Boston Scientific
BSX
BSX
555 hedge funds and large institutions have $27.2B invested in Boston Scientific in 2016 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 184 increasing their positions, 222 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $29.4B → $27.2B (-$2.18B)
17% less repeat investments, than reductions
Existing positions increased: 184 | Existing positions reduced: 222
44% less funds holding in top 10
Funds holding in top 10: 16 → 9 (-7)
Holders
555
Holding in Top 10
9
Calls
$78.3M
Puts
$57.4M
Top Buyers
| 1 | +$136M | |
| 2 | +$119M | |
| 3 | +$78.5M | |
| 4 |
Bank of New York Mellon
New York
|
+$71.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$67.9M |
Top Sellers
| 1 | -$150M | |
| 2 | -$146M | |
| 3 | -$85.7M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$76.6M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$61.1M |